首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12719篇
  免费   1330篇
  国内免费   333篇
耳鼻咽喉   202篇
儿科学   70篇
妇产科学   48篇
基础医学   1090篇
口腔科学   744篇
临床医学   1112篇
内科学   1431篇
皮肤病学   46篇
神经病学   1310篇
特种医学   635篇
外国民族医学   4篇
外科学   2298篇
综合类   1880篇
一般理论   1篇
预防医学   276篇
眼科学   1592篇
药学   397篇
  18篇
中国医学   925篇
肿瘤学   303篇
  2024年   11篇
  2023年   265篇
  2022年   347篇
  2021年   577篇
  2020年   669篇
  2019年   481篇
  2018年   518篇
  2017年   635篇
  2016年   522篇
  2015年   546篇
  2014年   958篇
  2013年   895篇
  2012年   853篇
  2011年   829篇
  2010年   718篇
  2009年   628篇
  2008年   613篇
  2007年   595篇
  2006年   507篇
  2005年   432篇
  2004年   328篇
  2003年   289篇
  2002年   263篇
  2001年   215篇
  2000年   157篇
  1999年   154篇
  1998年   144篇
  1997年   108篇
  1996年   101篇
  1995年   101篇
  1994年   83篇
  1993年   67篇
  1992年   65篇
  1991年   72篇
  1990年   56篇
  1989年   37篇
  1988年   40篇
  1987年   39篇
  1986年   57篇
  1985年   50篇
  1984年   73篇
  1983年   61篇
  1982年   57篇
  1981年   50篇
  1980年   36篇
  1979年   26篇
  1978年   28篇
  1977年   9篇
  1976年   7篇
  1975年   4篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的观察小儿推拿联合耳穴贴压治疗小儿变应性鼻炎(AR)肺虚感寒证的临床疗效。方法选取2019年1月至2020年6月在丽水市人民医院儿科治疗的AR肺虚感寒证患儿70例,采用随机数字表法分为治疗组和对照组,各35例。对照组给予常规西药治疗,治疗组给予小儿推拿联合耳穴贴压法治疗,2组均以1个月为1个疗程,1个疗程后统计临床疗效、中医证候评分、治疗前后血清免疫球蛋白E(IgE)和白介素-4(IL-4)水平变化以及复发情况。结果治疗组总有效率为91.43%(32/35),显著高于对照组的68.57%(24/35),2组比较,差异有统计学意义(P<0.05)。治疗前,2组中医证候评分比较,差异无统计学意义(P>0.05),具有可比性;治疗后,2组中医证候评分较同组治疗前明显降低(P<0.05),且治疗组降低更显著,差异有统计学意义(P<0.05)。治疗前,2组血清IgE、IL-4水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后,2组IgE、IL-4水平较同组治疗前明显升高(P<0.05),且治疗组升高更显著,差异有统计学意义(P<0.05)。2组随访6个月,治疗组复发率为10.53%(2/19),显著低于对照组的42.86%(6/14),2组比较,差异有统计学意义(P<0.05)。结论小儿推拿联合耳穴贴压治疗小儿AR肺虚感寒证疗效满意,可明显缓解临床症状,提高机体免疫力,降低复发率,值得临床推广应用。  相似文献   
2.
BackgroundIschemia reperfusion (I/R) play an imperative role in the expansion of cardiovascular disease. Sinomenine (SM) has been exhibited to possess antioxidant, anticancer, anti-inflammatory, antiviral and anticarcinogenic properties. The aim of the study was scrutinized the cardioprotective effect of SM against I/R injury in rat.MethodsRat were randomly divided into normal control (NC), I/R control and I/R + SM (5, 10 and 20 mg/kg), respectively. Ventricular arrhythmias, body weight and heart weight were estimated. Antioxidant, inflammatory cytokines, inflammatory mediators and plasmin system indicator were accessed.ResultsPre-treated SM group rats exhibited the reduction in the duration and incidence of ventricular fibrillation, ventricular ectopic beat (VEB) and ventricular tachycardia along with suppression of arrhythmia score during the ischemia (30 and 120 min). SM treated rats significantly (P < 0.001) altered the level of antioxidant parameters. SM treatment significantly (P < 0.001) repressed the level of creatine kinase MB (CK-MB), creatine kinase (CK) and troponin I (Tnl). SM treated rats significantly (P < 0.001) repressed the tissue factor (TF), thromboxane B2 (TXB2), plasminogen activator inhibitor 1 (PAI-1) and plasma fibrinogen (Fbg) and inflammatory cytokines and inflammatory mediators.ConclusionOur result clearly indicated that SM plays anti-arrhythmia effect in I/R injury in the rats via alteration of oxidative stress and inflammatory reaction.  相似文献   
3.
Amiodarone is the most potent antiarrhythmic drug available and is commonly prescribed to treat and prevent not only life-threatening ventricular arrhythmias but also atrial fibrillation (AF). The latest European Society of Cardiology AF guidelines state that amiodarone is recommended for long-term rhythm control in all AF patients but that other antiarrhythmic drugs should be considered first whenever possible, due to its extracardiac toxicity. In patients without significant or with only minimal structural heart disease, amiodarone is not listed as a possibility in their therapeutic scheme. Still, amiodarone is widely and liberally used, and is the most prescribed antiarrhythmic drug for patients with AF despite its high toxicity profile. Non-cardiovascular death was more frequent with amiodarone treatment than with a rate control strategy in AFFIRM, while meta-analyses suggest an association between amiodarone use in patients without structural heart disease and increased non-cardiovascular mortality. Severe or even fatal outcomes due to amiodarone may occur years after treatment initiation and are often not acknowledged by the prescribing physician, who may no longer be following the patient. The lack of widely accepted diagnostic criteria and symptom definitions may lead to underestimation of the incidence of severe side effects and of its toxicity. Unlike the underestimated risk of toxicity with amiodarone, severe complications associated with catheter ablation are usually directly ascribed to the treatment even by non-medical personnel, possibly resulting in overestimation of risks. This brief review will address the issue of amiodarone overuse and the frequent underestimation of its toxicity, while suggesting scenarios in which its use is entirely reasonable, and compare it with catheter ablation.  相似文献   
4.
在正畸治疗中,前后牙的转矩是形成美观笑线、建立适当咬合关系及保持正畸效果长期稳定性的重要因素。无托槽隐形矫治技术因其美观、舒适等优点,成为临床上患者首要选择的方案之一。但其对于前牙转矩控制的实现率和精准率仍有待提高。如何在使用无托槽隐形矫治器时精准实现上前牙转矩移动是临床医生关注的重点和难点。文章就无托槽隐形矫治中上前牙转矩控制影响因素研究进展做一综述,以期对临床方案设计、材料选择等方面提供指导。  相似文献   
5.
BackgroundInflammation surrounding the coronary arteries can be non-invasively assessed using pericoronary adipose tissue attenuation (PCAT). While PCAT holds promise for further risk stratification of patients with low coronary artery disease (CAD) prevalence, its value in higher risk populations remains unknown.MethodsCORE320 enrolled patients referred for invasive coronary angiography with known or suspected CAD. Coronary computed tomography angiography (CCTA) images were collected for 381 patients for whom clinical outcomes were assessed 5 years after enrollment. Using semi-automated image analysis software, PCAT was obtained and normalized for the right coronary (RCA), left anterior descending (LAD), and left circumflex arteries (LCx). The association between PCAT and major adverse cardiovascular events (MACE) during follow up was assessed using Cox regression models.ResultsThirty-seven patients were excluded due to technical failure. For the remaining 344 patients, median age was 62 (interquartile range, 55–68) with 59% having ≥1 coronary artery stenosis of ≥50% by quantitative coronary angiography. Mean attenuation values for PCAT in RCA, LAD, and LCx were ?74.9, ?74.2, and ?71.2, respectively. Hazard ratios and 95% confidence intervals (CI) for normalized PCAT in the RCA, LAD, and LCx for MACE were 0.96 (CI: 0.75–1.22, p ?= ?0.71), 1.31 (95% CI: 0.96–1.78, p ?= ?0.09), and 0.98 (95% CI: 0.78–1.22, p ?= ?0.84), respectively. For death, stroke, or myocardial infarction only, hazard ratios were 0.68 (0.44–1.07), 0.85 (0.56–1.29), and 0.57 (0.41–0.80), respectively.ConclusionsIn patients referred for invasive coronary angiography with suspected CAD, PCAT did not predict MACE during long term follow up. Further studies are needed to understand the relationship of PCAT with CAD risk.  相似文献   
6.
7.
目的 探讨颈前后联合入路手术治疗椎间孔骑跨型臂丛神经鞘瘤的疗效。方法 回顾性分析2018年9月至2021年6月收治的7例椎间孔骑跨型臂丛神经鞘瘤的临床资料,其中6例采用颈部锁骨上窝臂丛神经肿瘤切除术联合后路颈椎管内肿瘤切除术,1例采用颈部锁骨上下窝臂丛神经肿瘤切除术联合后路颈椎管内肿瘤切除术。结果 术中未使用椎体融合、钉棒系统内固定等,颈椎各关节未破坏,颈部活动能力较术前无受限。7例肿瘤均全切除,术后病理检查均证实为神经鞘瘤。术后无脑脊液漏。5例术后症状改善;2例术后同侧肢体肌力下降,药物治疗后恢复至术前水平。7例术后随访9~27个月,平均14.7个月;影像学检查未见肿瘤复发,术后患侧肢体肌力未见下降,无新增神经功能缺失,肌电图示臂丛神经损害好转。结论 对于椎间孔骑跨型臂丛神经鞘瘤,颈前后联合入路手术可以完整切除肿瘤,无需行颈椎内固定,创伤小,可获得良好疗效。  相似文献   
8.
9.

随着白内障手术步入了微创精准的屈光时代,对于围手术期感染控制提出了更高的要求。近年来,无滴眼液的白内障手术被提出并逐步应用于临床,其是基于白内障手术中联合不同局部注药形式,将抗生素及类固醇等药物通过即时或缓释等方式应用于术眼,使患者在整个围手术期均不需使用滴眼液。在达到术后抗炎、抗感染目的的同时,也能减少患者、患者家属及医生的负担。本文对无滴眼液的白内障手术的概念、联合用药方式、包括联合前房注射抗生素、曲安奈德与莫西沙星的混合注射剂(triamcinolone acetonide and moxifloxacin hydrochloride, TriMoxi)和曲安奈德、莫西沙星与万古霉素的混合注射剂(triamcinolone -moxifloxacin and vancomycin,TriMoxiVanc)玻璃体腔注射、联合地塞米松泪小点塞植入、持续或缓释药物传递机制等、以及其有效性及安全性等内容进行综述,以期为白内障术后感染预防提供新的思路与方向。  相似文献   

10.

Background

Alcohol intoxication impairs inhibitory control, resulting in disinhibited, impulsive behavior. The anterior cingulate cortex (ACC) plays an essential role in a range of executive functions and is sensitive to the effects of alcohol, which contributes to the top-down cognitive dysregulation. This study used a multimodal approach to examine the acute effects of alcohol on the neural underpinnings of inhibitory control, inhibition failures, and neurobehavioral optimization as reflected in trial-to-trial dynamics of post-error adjustments.

Methods

Adult social drinkers served as their own controls by participating in the Go/NoGo task during acute alcohol and placebo conditions in a multi-session, counterbalanced design. Distributed source modeling of the magnetoencephalographic signal was combined with structural magnetic resonance imaging to characterize the spatio-temporal dynamics of inhibitory control in the time-frequency domain.

Results

Successful response inhibition (NoGo) elicited right-lateralized event-related theta power (4 to 7 Hz). Errors elicited a short-latency increase in theta power in the dorsal (dACC), followed by activity in the rostral (rACC), which may underlie an affective “oh, no!” orienting response to errors. Error-related theta in the dACC was associated with subsequent activity of the motor areas on the first post-error trial, suggesting the occurrence of post-error output adjustments. Importantly, a gradual increase of the dACC theta across post-error trials closely tracked improvements in accuracy under placebo, which may reflect cognitive control engagement to optimize response accuracy. In contrast, alcohol increased NoGo commission errors, dysregulated theta during correct NoGo withholding, and abolished the post-error theta enhancement of cognitive control.

Conclusions

Confirming the sensitivity of frontal theta to inhibitory control and error monitoring, the results support functional and temporal dissociation along the dorso-rostral axis of the ACC and the deleterious effects of alcohol on the frontal circuitry subserving top-down regulation. Over time, alcohol-induced disinhibition may give rise to compulsive drinking and contribute to alcohol misuse.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号